USPTO serial 76154643
RIAVAN
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- ROTH, JASON I
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with RIAVAN?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Owner
BRISTOL-MYERES SQUIBB PHARMA COMPANY
WILMINGTON, DE
Other trademarks owned by BRISTOL-MYERES SQUIBB PHARMA COMPANY
DuPont Pharmaceuticals Company
Wilmington, DE
DuPont Pharmaceuticals Company
Wilmington, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Blair Q. Ferguson
G MATHEW LOMBARD BRISTOL-MYERS SQUIBB COMPANY345 PARK AVENEW YORK, NY 10154UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | PHARMACEUTICAL PREPARATIONS, FOR THE TREATMENT OF CARDIOVASCULAR DISEASES, CENTRAL NERVOUS SYSTEM DISEASES, CANCER, INFLAMMATION AND INFLAMMATORY DISEASES, RESPIRATORY AND INFECTIOUS DISEASES AND FOR DIAGNOSTIC IMAGING | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BRISTOL-MYERES SQUIBB PHARMA COMPANY
- Other trademarks owned by DuPont Pharmaceuticals Company
- Other trademarks owned by DuPont Pharmaceuticals Company
- Other trademarks in Class 005
- Similar marks named RIAVAN
- Prosecution event ABN6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 6, 2003 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Apr 10, 2003 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Feb 6, 2003 | EXT3 | SOU EXTENSION 3 FILED | — |
| Feb 6, 2003 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Aug 27, 2002 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Aug 20, 2002 | EXT2 | SOU EXTENSION 2 FILED | — |
| Aug 20, 2002 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Jul 24, 2002 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 26, 2002 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Feb 6, 2002 | EXT1 | SOU EXTENSION 1 FILED | — |
| Sep 4, 2001 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 12, 2001 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 30, 2001 | NPUB | NOTICE OF PUBLICATION | — |
| Mar 19, 2001 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 14, 2001 | DOCK | ASSIGNED TO EXAMINER | — |